The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
about
Increased expression of secreted frizzled-related protein 4 in polycystic kidneysInteraction between RGS7 and polycystinCardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 genePolycystin-1 is required for stereocilia structure but not for mechanotransduction in inner ear hair cells.Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney diseaseAutomatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients.The cell biology of polycystic kidney diseaseAutopsy report with clinical and pathophysiologic discussion of autosomal dominant adult polycystic kidney diseaseFrequency and clinical profile of patients with polycystic kidney disease in southern Brazil.Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD.Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.Cell biology of polycystin-2.Polycystic kidney disease: an unrecognized emerging infectious disease?Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.Function and regulation of TRPP2 at the plasma membrane.Polycystic kidney disease: pathogenesis and potential therapies.Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.Polycystic kidney disease: huge kidneys, huge problems, huge progress.Genetic Mechanisms of ADPKD.Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.The epidermal growth factor receptor juxtamembrane domain has multiple basolateral plasma membrane localization determinants, including a dominant signal with a polyproline core.The cytoplasmic juxtamembrane domain of the epidermal growth factor receptor contains a novel autonomous basolateral sorting determinant.Risk of aortic aneurysm and dissection in patients with autosomal-dominant polycystic kidney disease: a nationwide population-based cohort study.Combined renin-angiotensin-aldosterone system blockade and statin therapy effectively reduces the risk of cerebrovascular accident in autosomal dominant polycystic kidney disease: a nationwide population-based cohort study.PKD2 functions as an epidermal growth factor-activated plasma membrane channel.Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition.Large Retroperitoneal Haemorrhage Following Cyst Rupture in a Patient with Autosomal Dominant Polycystic Kidney Disease.Apelin/APJ system: A novel potential therapy target for kidney disease.Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation.
P2860
Q24336816-89616EE7-E3AC-4B00-ADD5-D8C72A3610DAQ24653605-0DEBBFA0-2E1C-4CEB-9E00-CABA8CB28F2FQ28507278-93116B69-628E-46BC-91CE-C7C977B49A56Q30428257-CA340328-45E5-4174-AF4F-06F3F77C8977Q33395144-77C02623-97DA-4D62-B833-84293D687433Q33700489-73EE0F77-2AD4-4A1A-A33E-29343D9DC93DQ33801052-AB72C0D4-55F8-40EB-B3DE-0327389A7276Q34149966-BDCBECC9-828B-49BA-A547-9F3934623729Q34278702-D53C0C3A-8EEB-40FA-B2E5-22B22DEAB453Q34755459-00476F7B-0A86-4B90-902F-36AD4CCC02BEQ36158683-59DB57D5-D31F-4915-86F1-2908F18AB6DEQ36384928-DDF4E699-398F-4557-B118-756CFEDB717BQ36644604-45A5E878-FBFF-4A76-B16B-C486B2A00F46Q37064098-989F9AD7-7F68-499B-AF77-4FBF7ACF7ABDQ37119771-6025A68E-F76E-44AE-9665-D1CBD3EEDC46Q37264334-10C9B7BB-BAA4-414C-A7A6-6D01BC90D721Q37819164-3254B73D-08BE-4777-96DB-6AE02943A971Q38030726-C3728E79-6060-42FA-ADBB-04E55DF1FDC1Q38298568-1C84AD17-F8C7-43C7-99BB-BD1E4099F2E3Q38978453-EE6824F4-B74E-48EB-B13C-CCAD90742409Q39078035-410F4AA4-312C-4EB8-BA7D-204DBA8EAE74Q40713310-A4916120-5EB6-4CF2-BA09-BAB840126B91Q41069175-35DC8C0B-EB58-4120-A842-CEC6BA232BACQ41340444-34412669-E039-4F1E-86D9-2D0D400E8073Q42119273-4BD80EA0-CD1B-485B-B486-EF005FEE3597Q42537525-7B1A99F8-1D4D-486B-BB4C-76BCDF1173C7Q44822420-8B95C6E8-06BB-4108-9FCD-D63A1A9DFD09Q45741522-D4D0B16F-1102-4243-9419-76E43ABA7716Q47933922-10B74386-A7D5-4993-B15D-A2A157221AC3Q55500213-526055E5-FE45-4ACC-876C-B1250FDC16C2
P2860
The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The etiology, pathogenesis, an ...... dney disease: recent advances.
@en
type
label
The etiology, pathogenesis, an ...... dney disease: recent advances.
@en
prefLabel
The etiology, pathogenesis, an ...... dney disease: recent advances.
@en
P1476
The etiology, pathogenesis, an ...... dney disease: recent advances.
@en
P2093
Grantham JJ
P304
P356
10.1016/S0272-6386(96)90378-9
P577
1996-12-01T00:00:00Z